EAM Global Investors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

EAM Global Investors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-186,109	Closed	-$4.77M	–	252
2021 Q2	$4.77M	Hold	186,109	–	–	1.32%	7
2021 Q1	$3.39M	Sell	186,109 -43,078	-19%	-$716K	0.94%	20
2020 Q4	$2.65M	Buy	+229,187	New	+$2.1M	0.72%	60
2020 Q1	–	Sell	-261,038	Closed	-$2M	–	138
2019 Q4	$2M	Buy	+261,038	New	+$1.52M	0.8%	53
2019 Q1	–	Sell	-256,781	Closed	-$1.05M	–	162
2018 Q4	$1.05M	Buy	256,781 +52,111	+25%	+$272K	0.58%	93
2018 Q3	$1.4M	Buy	+204,670	New	+$1.21M	0.57%	86

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

EAM Global Investors's CDMO Position: Q3 2021 in Review

EAM Global Investors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 186,109 shares — an estimated $4.77M sold.

EAM Global Investors first reported a position in CDMO in Q3 2018 and held it in 6 quarters. The position peaked at $4.77M in Q2 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

EAM Global Investors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
EAM Global Investors sold 186,109 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $4.77M.
EAM Global Investors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
EAM Global Investors's Avid Bioservices, Inc. Common Stock position peaked at $4.77M in Q2 2021.
161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.